Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jul 14;118(2):231-9.
doi: 10.1182/blood-2011-04-285981. Epub 2011 May 26.

Transcription factor networks in erythroid cell and megakaryocyte development

Affiliations
Review

Transcription factor networks in erythroid cell and megakaryocyte development

Louis C Doré et al. Blood. .

Abstract

Erythroid cells and megakaryocytes are derived from a common precursor, the megakaryocyte-erythroid progenitor. Although these 2 closely related hematopoietic cell types share many transcription factors, there are several key differences in their regulatory networks that lead to differential gene expression downstream of the megakaryocyte-erythroid progenitor. With the advent of next-generation sequencing and our ability to precisely define transcription factor chromatin occupancy in vivo on a global scale, we are much closer to understanding how these 2 lineages are specified and in general how transcription factor complexes govern hematopoiesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Erythroid cells and megakaryocytes are derived from a common progenitor. The decision of whether the MEP should give rise to red cell or platelet lineages is controlled by an array of transcription factors and microRNAs.
Figure 2
Figure 2
A complex regulatory network controls MEP cell fate. The relative levels of expression of key regulatory factors, including GATA-1, GATA-2, SCL, and PU.1, are predicted to control the output toward erythroid cells (marked by EKLF) or megakaryocytes (marked by Fli-1). Arrows indicate gene activation; and blunted lines, repression.

Similar articles

Cited by

References

    1. Debili N, Coulombel L, Croisille L, et al. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood. 1996;88(4):1284–1296. - PubMed
    1. Vannucchi AM, Paoletti F, Linari S, et al. Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. Blood. 2000;95(8):2559–2568. - PubMed
    1. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193–197. - PubMed
    1. Stachura DL, Chou ST, Weiss MJ. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. Blood. 2006;107(1):87–97. - PMC - PubMed
    1. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 2002;21(19):5225–5234. - PMC - PubMed

Publication types

MeSH terms

Substances